Metabolic syndrome, with or without AD, has been associated with impaired brain insulin signaling, including disruptions in IRS-1 and AKT pathways, indicative of a brain insulin-resistant state13–15,54,78. This evidence concerns the gene AKT1 and Alzheimer disease.